Intrauterine device for contraception
33 results
1 - 33
Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception- LNG-IUD is noninferior to copper IUD for emergency contraception
- Long-acting contraception associated with reduction in repeat abortion
- Long-acting contraceptive methods effective longer than approved duration
- Long-acting contraception associated with low failure
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Small increase in risk for breast cancer associated with levonorgestrel-releasing intrauterine device
- Contraceptive implant and LNG-IUD both reduce pelvic pain associated with endometriosis
- Early postpartum insertion of long-acting reversible contraceptive is associated with fewer pregnancies
- Low incidence of pregnancy with same-day-start contraception
- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- The past use of an intrauterine device is not associated with infertility, but a past Mycoplasma genitalium infection is
- Free contraception associated with reduced long-term pregnancy and birth rates in teens (CHOICE study)
- Levonorgestrel is ineffective emergency contraception for obese women
- Cervical-uterine instillation with mepivacaine modestly reduces pain during intrauterine device insertion
- Women more likely to use EC with advance provision
- Access to free LARC associated with decreased risk of unintended pregnancy
- Postpartum IUD placement at 2-4 wk = 6-8 wk, with caveats
- Intracervical block with 2% lidocaine reduces pain associated with LNG-IUS placement
- Letrozole is noninferior to mifepristone for the management of missed miscarriage
- Elagolix with add-back therapy effective for premenopausal heavy menstrual bleeding associated with fibroids